Charles River Laboratories | CRL - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
Agilent USD 2.27B 35M 2026-03
Align Technology USD 1.91B 14.16M 2026-03
Bio-Rad Laboratories USD 917M 400M 2026-03
Bruker USD 1.36B 75.9M 2026-03
Cardinal Health USD 41.99B 1.33B 2026-03
Charles River Laboratories USD 1.09B 26.61M 2026-03
Cigna USD 52.61B 3.74B 2026-03
Concord Medical Services Hldg CNY 2.45B 1.12B 2025-06
CVS Health USD 86.41B 2.29B 2026-03
Danaher USD 7.46B 653M 2026-03
Dentsply International USD 1.21B 136M 2026-03
Elevance Health USD 45.31B 4.27B 2026-03
Humana USD 21.51B 5.16B 2026-03
Illumina USD 1.57B 19M 2026-03
Incyte USD 1.49B 25.52M 2026-03
Intrexon USD 23.02M 38K 2024-06
IQVIA Holdings USD 8.33B 9M 2026-03
Laboratory Of America USD 2.64B 182.5M 2026-03
Lakefront Biotherapeutics EUR 100.42M 52.44M 2026-03
Lonza CHF 3.57B 421M 2025-12
McKesson USD 67.02B 1.11B 2026-03
Merck EUR 9.35B 307M 2026-03
Mettler Toledo International USD 1.11B 89.76M 2026-03
Novartis USD 31.37B 4.1B 2026-03
Pfizer USD 34.35B 2.64B 2026-03
Quest Diagnostics USD 2.18B 101M 2026-03
Revvity USD 1.24B 92.6M 2026-03
Thermo Fisher Scientific USD 14.62B 568M 2026-03
United Therapeutics USD 599.1M 38.5M 2026-03
UnitedHealth USD 114.12B 773M 2026-03
Veradigm USD 230.31M 22.78M 2022-12
Waters USD 1.24B 11.8M 2025-12
West Pharmaceutical Services USD 674M 19.1M 2026-03